Core Scientific, Inc. Form 8-K Summary
Business Context and Reporting Period
Core Scientific, Inc. furnished this Current Report on Form 8-K on May 8, 2024, reporting financial results for the first fiscal quarter ended March 31, 2024. The filing relates to the company’s quarterly results announcement and accompanying corporate presentation.
Financial Results and Key Metrics
The filing text identifies the release of quarterly financial results but does not include the underlying revenue, profit or loss, cash flow, margin, debt, liquidity, operating, or other financial metrics. Those details were furnished in Exhibit 99.1, the May 8, 2024 press release, and Exhibit 99.2, the company presentation; the exhibit contents are not included in the provided source text.
Material Changes Versus the Prior Comparable Period
The provided filing text does not state specific changes versus the first quarter of the prior year or the immediately preceding quarter.
Guidance, Outlook, Risks, and Unusual Items
The filing text does not provide management guidance, outlook commentary, risk disclosures, contingencies, or unusual items. It only states that the company released its quarterly results and related presentation.
The information under Items 2.02 and 7.01, including the exhibits, was furnished and is not deemed filed for purposes of Section 18 of the Exchange Act or incorporated by reference into other Securities Act filings.
Important Facts to Verify
- Obtain and review Exhibit 99.1 for reported revenue, earnings, cash flow, margins, debt, liquidity, and operating metrics.
- Review Exhibit 99.2 for management commentary, outlook, guidance, capacity, and business updates.
- Compare first-quarter 2024 results with the prior comparable period and assess the drivers of any changes.
- Verify any non-GAAP measures, reconciliations, liquidity disclosures, and unusual or one-time items in the exhibits.
- Note that the filing reports securities traded under CORZ, CORZW, and CORZZ on Nasdaq, including warrants with stated exercise prices of $6.81 and $0.01 per share.